Oncolytic adenovirus-mediated expression of decorin facilitates CAIX-targeting CAR-T therapy against renal cell carcinoma
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Oncolytic adenovirus-mediated expression of decorin facilitates CAIX-targeting CAR-T therapy against renal cell carcinoma
Authors
Keywords
oncolytic adenovirus, chimeric antigen receptor T cell, Decorin, carbonic anhydrase IX, renal cell carcinoma
Journal
Molecular Therapy-Oncolytics
Volume 24, Issue -, Pages 14-25
Publisher
Elsevier BV
Online
2021-11-30
DOI
10.1016/j.omto.2021.11.018
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Decorin-mediated suppression of tumorigenesis, invasion, and metastasis in inflammatory breast cancer
- (2021) Xiaoding Hu et al. Communications Biology
- Immunotherapies and immunomodulatory approaches in clinical trials - a mini review
- (2021) Mohd. Iqbal Yatoo et al. Human Vaccines & Immunotherapeutics
- Oncolytic virotherapy reverses the immunosuppressive tumor microenvironment and its potential in combination with immunotherapy
- (2021) Yalei Zhang et al. Cancer Cell International
- Renal cell carcinoma pathology in 2021: ‘new need for renal cancer immune profiling’
- (2021) Bettina Sobottka et al. CURRENT OPINION IN UROLOGY
- Navigating CAR-T cells through the solid-tumour microenvironment
- (2021) Andrew J. Hou et al. NATURE REVIEWS DRUG DISCOVERY
- Development of oncolytic viruses for cancer therapy
- (2021) Noraini Abd-Aziz et al. Translational Research
- A Review of Chimeric Antigen Receptor T-Cell Therapy for Myeloma and Lymphoma
- (2021) Shebli Atrash et al. OncoTargets and Therapy
- CAR-T cell therapy: current limitations and potential strategies
- (2021) Robert C. Sterner et al. Blood Cancer Journal
- Tissues and Tumor Microenvironment (TME) in 3D: Models to Shed Light on Immunosuppression in Cancer
- (2021) Teresa Ho et al. Cells
- Efficacy of an Oncolytic Adenovirus Driven by a Chimeric Promoter and Armed with Decorin Against Renal Cell Carcinoma
- (2020) Wen Zhang et al. HUMAN GENE THERAPY
- Oncolytic virus promotes tumor-reactive infiltrating lymphocytes for adoptive cell therapy
- (2020) Mathilde Feist et al. CANCER GENE THERAPY
- Carbonic Anhydrase IX (CA9) Expression in Multiple Renal Epithelial Tumor Subtypes
- (2020) Nicholas Baniak et al. HISTOPATHOLOGY
- Cellular immunotherapies for cancer
- (2020) Conall Hayes IRISH JOURNAL OF MEDICAL SCIENCE
- Moving Immune Therapy Forward Targeting TME
- (2020) Kayla F Goliwas et al. PHYSIOLOGICAL REVIEWS
- Combining oncolytic virus with FDA approved pharmacological agents for cancer therapy
- (2020) Wei Zhang et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- Glutathione Metabolism in Renal Cell Carcinoma Progression and Implications for Therapies
- (2019) Xiao et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Clinical investigation of CAR T cells for solid tumors: Lessons learned and future directions
- (2019) Stephen J. Bagley et al. PHARMACOLOGY & THERAPEUTICS
- Potent antitumor effect of tumor microenvironment-targeted oncolytic adenovirus against desmoplastic pancreatic cancer
- (2017) Yan Li et al. INTERNATIONAL JOURNAL OF CANCER
- Oncolytic adenovirus coexpressing interleukin-12 and decorin overcomes Treg-mediated immunosuppression inducing potent antitumor effects in a weakly immunogenic tumor model
- (2016) Eonju Oh et al. Oncotarget
- Decorin-mediated inhibition of the migration of U87MG glioma cells involves activation of autophagy and suppression of TGF-β signaling
- (2016) Ting Yao et al. FEBS Open Bio
- Decorin-expressing adenovirus decreases collagen synthesis and upregulates MMP expression in keloid fibroblasts and keloid spheroids
- (2015) Won Jai Lee et al. EXPERIMENTAL DERMATOLOGY
- Treatment of Metastatic Renal Cell Carcinoma With CAIX CAR-engineered T cells: Clinical Evaluation and Management of On-target Toxicity
- (2013) Cor HJ Lamers et al. MOLECULAR THERAPY
- Carbonic Anhydrase IX in Renal Cell Carcinoma: Implications for Prognosis, Diagnosis, and Therapy
- (2010) Alexander B. Stillebroer et al. EUROPEAN UROLOGY
- Jekyll and Hyde: the role of the microenvironment on the progression of cancer
- (2010) Michael Allen et al. JOURNAL OF PATHOLOGY
- Defects in Innate Immunity Render Breast Cancer Initiating Cells Permissive to Oncolytic Adenovirus
- (2010) Laura Ahtiainen et al. PLoS One
- Possible involvement of regulatory T cells in tumor onset and progression in primary breast cancer
- (2008) Masahiro Ohara et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Cancer therapy with local oncolysis and topical cytokine secretion
- (2007) Masatoshi Tagawa Frontiers in Bioscience-Landmark
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More